THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 83 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $623,000 | +66.6% | 59,032 | +15.2% | 0.00% | +100.0% |
| Q3 2021 | $374,000 | -50.8% | 51,250 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $760,000 | -44.2% | 51,250 | -22.6% | 0.00% | -60.0% |
| Q1 2021 | $1,362,000 | +16.0% | 66,250 | 0.0% | 0.01% | +25.0% |
| Q4 2020 | $1,174,000 | +128.0% | 66,250 | +91.8% | 0.00% | +100.0% |
| Q3 2020 | $515,000 | +181.4% | 34,550 | +287.6% | 0.00% | +100.0% |
| Q2 2020 | $183,000 | -9.9% | 8,914 | 0.0% | 0.00% | -50.0% |
| Q1 2020 | $203,000 | +8.6% | 8,914 | -7.1% | 0.00% | +100.0% |
| Q3 2019 | $187,000 | -38.9% | 9,600 | -50.0% | 0.00% | -50.0% |
| Q2 2019 | $306,000 | -9.2% | 19,200 | +64.1% | 0.00% | 0.0% |
| Q1 2019 | $337,000 | +51.1% | 11,700 | +21.9% | 0.00% | +100.0% |
| Q4 2018 | $223,000 | -33.8% | 9,600 | -17.9% | 0.00% | -50.0% |
| Q3 2018 | $337,000 | +22.5% | 11,700 | -2.5% | 0.00% | 0.0% |
| Q2 2018 | $275,000 | -51.2% | 12,000 | -50.0% | 0.00% | -50.0% |
| Q1 2018 | $563,000 | -15.0% | 24,000 | -2.0% | 0.00% | -20.0% |
| Q4 2017 | $662,000 | 0.0% | 24,500 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $662,000 | -32.0% | 24,500 | 0.0% | 0.01% | -37.5% |
| Q2 2017 | $974,000 | +9.4% | 24,500 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $890,000 | +6.2% | 24,500 | -7.5% | 0.01% | -11.1% |
| Q4 2016 | $838,000 | -2.8% | 26,500 | +8.2% | 0.01% | -10.0% |
| Q3 2016 | $862,000 | +53.7% | 24,500 | 0.0% | 0.01% | +66.7% |
| Q2 2016 | $561,000 | +87.0% | 24,500 | +50.3% | 0.01% | +50.0% |
| Q1 2016 | $300,000 | -5.4% | 16,300 | -15.1% | 0.00% | 0.0% |
| Q4 2015 | $317,000 | +69.5% | 19,200 | +12.9% | 0.00% | +100.0% |
| Q3 2015 | $187,000 | -8.3% | 17,000 | +8.3% | 0.00% | 0.0% |
| Q2 2015 | $204,000 | -22.1% | 15,700 | +4.0% | 0.00% | -33.3% |
| Q1 2015 | $262,000 | – | 15,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,269,584 | $69,497,223,000 | 12.98% |
| Newtyn Management, LLC | 1,375,000 | $13,145,000 | 3.15% |
| Chescapmanager LLC | 1,166,574 | $11,152,000 | 1.51% |
| Baupost Group | 13,643,333 | $130,430,000 | 1.40% |
| Weiss Asset Management LP | 5,412,487 | $51,743,000 | 1.07% |
| CM Management, LLC | 120,000 | $1,147,000 | 0.96% |
| Orbimed Advisors | 3,254,713 | $31,115,000 | 0.50% |
| King Wealth Management Group | 122,000 | $1,166,000 | 0.23% |
| Woodline Partners LP | 1,326,653 | $12,683,000 | 0.21% |
| PDT Partners, LLC | 192,701 | $1,842,000 | 0.16% |